Suchergebnisse - "Hertle, Sabine"

PubPharm (5)

1

STIMULUS-MDS2 design and rationale : a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2

enthalten in: Future oncology (London, England) | 2023

von Zeidan, A. | Giagounidis, A. | Sekeres, M. | +6

2

Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib : a Phase 1b, multicentre study

enthalten in: British journal of cancer | 2020

von Gelderblom, H. | Jones, R. | George, S. | +11

3

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia

enthalten in: Blood | 2019

von Hijiya, N. | Maschan, A. | Rizzari, C. | +17

4

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase : ENESTchina

enthalten in: Blood | 2015

von Wang, J. | Shen, Z. | Saglio, G. | +17

5

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

enthalten in: Blood | 2015

von Wang, J. | Shen, Z. | Saglio, G. | +17

1
[1]